Section Arrow
Quote
BIO B.NYSE
- Bio-Rad Laboratories
Quotes are at least 15-min delayed:2025/01/21 02:27 EST
Last
 --
-- (--)
Day High 
-- 
Prev. Close
341 
1-M High
341 
Volume 
4 
Bid
--
Ask
375.54
Day Low
-- 
Open
-- 
1-M Low
325.6 
Market Cap 
9.55B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 323.16 
20-SMA 324.15 
50-SMA 341.77 
52-W High 352.91 
52-W Low 279.91 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-28.08/12.47
Enterprise Value
10.91B
Balance Sheet
Book Value Per Share
267.45
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
2.67B
Operating Revenue Per Share
97.17
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed：2025/01/21 02:27 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.